In our experiments, C6 glioma cells were highly sensitive to the nonselective LOX inhibitor NDGA and the selective 12-LOX inhibitor baicalein, with a weak response to the selective 5-LOX inhibitor zileuton. Here, ALOX5 is linked to glioma.